13
Participants
Start Date
July 31, 2012
Primary Completion Date
February 16, 2023
Study Completion Date
February 16, 2023
Placebo
3 tablets twice daily of matching placebo during the placebo phase.
Citric Acid
3, 10 mEq tablets of H3Cit twice daily during the H3Cit phase (60 mEq H3Cit per day)
Potassium Citrate
2, 10 mEq K3Cit tablets and 1 placebo tablet twice daily during the K3Cit phase (40 mEq K3Cit per day)
UT Southwestern Medical Center, Dallas
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
University of Texas Southwestern Medical Center
OTHER